Home > PJ > News / Daily News

Return to PJ Online Home Page

The Pharmaceutical Journal Vol 267 No 7167 p415-420
29 September 2001

This article
Reprint
Photocopy


News summary


Patients not warned about side effects of psychiatric drugs

Patients are often not warned about the side effects of psychiatric drugs prescribed by their doctors, says the mental health charity Mind.

Patients with mental health problems are encouraged by Mind to report adverse side effects to psychiatric drugs through the charity’s own yellow card scheme. Mind analysed 502 reports sent in by patients between March and July this year and found that 61 per cent of respondents said that they had not been given enough information about their drugs’ side effects. In addition, 63 per cent of respondents reported that they decided to stop taking their medicines, mainly because of unacceptable side effects. The analysis revealed that the psychiatric drugs most commonly reported were the older anti-psychotics (22 per cent of all side effects reported), selective serotonin reuptake inhibitor antidepressants (18 per cent), atypical antipsychotics (14 per cent), and antimanic drugs (13 per cent).

Mind launched its yellow card scheme in 1995 in response, it says, to under-reporting of side effects via the Committee on Safety of Medicines’ yellow card scheme (PJ, 27 May 1995, p717). The charity’s scheme allows patients to report their own reactions to drugs, which are then passed on to the CSM.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal